the nasal potential difference (npd) test – diagnosing cystic fibrosis
Published 9 years ago • 20K plays • Length 4:53Download video MP4
Download video MP3
Similar videos
-
0:53
pd-l1 biomarker status: to test or not to test? (conclusion)
-
3:40
lisa creagh's holding time at royal brompton hospital
-
49:35
cystic fibrosis and chronic rhinosinusitis
-
1:31:22
biopsy or not biopsy: where to draw the lines
-
1:52:31
nacfc 2022 | s01: design of clinical trials to evaluate nucleotide-based interventions
-
50:04
genetic testing: promises and pitfalls
-
19:33
noninvasive assessment of nafld/nash
-
1:00
dr. naidoo discusses biomarker testing for checkpoint inhibitors
-
0:38
when was narcissism discovered for the first time?
-
1:43
fibrosis, the failing heart, and endotrophin | nordic bioscience
-
1:23
can genetics predict atrial fibrillation (afib)? professor diane fatkin's research
-
19:03
cardiovascular risk in nafld - jorn m. schattenberg
-
3:01
amulet™device in non-valvular atrial fibrillation (nvaf)
-
2:28
the difference between hiding and living: atrial fibrillation | norton heart & vascular institute
-
0:15
is there a cure for narcissism?
-
3:06
recurrent ovarian cancer: choosing a parp inhibitor
-
2:59
new gene sites discovered affecting nonalcoholic fatty liver disease (nafld)
-
3:29
are there clinically significant distinctions between pd-1 and pd-l1?